The store will not work correctly when cookies are disabled.
6-Phenyl-4-(1-piperidinyl)-2-thioxo-1,2-dihydropyrimidine-5-carbonitrile
ID: ALA2415047
PubChem CID: 45028811
Max Phase: Preclinical
Molecular Formula: C16H16N4S
Molecular Weight: 296.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1c(N2CCCCC2)nc(=S)[nH]c1-c1ccccc1
Standard InChI: InChI=1S/C16H16N4S/c17-11-13-14(12-7-3-1-4-8-12)18-16(21)19-15(13)20-9-5-2-6-10-20/h1,3-4,7-8H,2,5-6,9-10H2,(H,18,19,21)
Standard InChI Key: MNLBQXRHEKOUCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
22.8368 -15.7663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8368 -16.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5558 -17.0061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2706 -16.5900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2706 -15.7663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5558 -15.3502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9854 -15.3502 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.1220 -17.0061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5558 -17.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4072 -17.4180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8368 -18.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8368 -19.0698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5558 -19.4858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2706 -19.0698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2706 -18.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1232 -15.3548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1267 -14.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4172 -14.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7015 -14.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6999 -15.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4140 -15.7707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 2 0
5 7 2 0
2 8 1 0
3 9 1 0
8 10 3 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
1 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.40 | Molecular Weight (Monoisotopic): 296.1096 | AlogP: 3.67 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.71 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.64 | CX Basic pKa: ┄ | CX LogP: 2.15 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: -1.42 |
References
1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT.. (2013) Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives., 66 [PMID:23811090] [10.1016/j.ejmech.2013.05.028] |